Kayla Switalla • UCSF Profiles (original) (raw)

  1. A prospective single-arm pilot study evaluating [F-18]fluoroestradiol dedicated breast PET in invasive lobular carcinoma after neoadjuvant endocrine therapy. Breast Cancer Res. 2026 Apr 11. Switalla KM, Onishi N, Jones EF, Lawhn-Heath C, Ray KM, Hathi DK, Carmona-Bozo JC, Metanat P, Lopes AJ, Falade IO, Quirarte A, Gottipati S, Guo R, Molina-Vega J, Pullakhandam K, Bareng TJ, Watkins M, Chien AJ, Joe BN, Esserman LJ, Hylton N, Mukhtar RA. PMID: 41965734.
    View in: PubMed Mentions:
  2. Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial. Ann Surg Oncol. 2025 Oct; 32(11):8243-8253. Mukhtar RA, Dimitroff K, Yau C, Chien AJ, Connolly EP, Howard-McNatt M, Rao R, Ladores V, Golshan M, Sauder CA, Ahmed K, Lancaster R, Fox J, Gutnik L, Lee MC, Tchou J, Prionas N, Arciero CA, Reyna C, Kuerer H, Switalla K, Taunk N, Tuttle TM, Moran MS, Postlewait LM, Perlmutter J, DeMichele A, Yee D, Hylton N, Symmans WF, Rugo HS, Shatsky R, Isaacs C, Esserman LJ, Van't Veer L, Boughey JC. PMID: 40705266; PMCID: PMC12494636.
    View in: PubMed Mentions: 1 Fields:
    Translation:HumansCTClinical Trials
  3. Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial. Ann Surg Oncol. 2025 Oct; 32(11):8211-8219. Kaur M, Dimitroff K, Boughey JC, Esserman LJ, Yau C, Tchou J, Quirarte A, Lee MC, Howard-McNatt MM, Switalla K, Kuerer H, Sauder C, Postlewait LM, Arciero C, Rao R, Wallace A, Reyna C, Ahmed K, Gutnik L, Taunk N, Perlmutter J, DeMichele A, Yee D, Hylton NM, Symmans WF, Rugo HS, Shatsky RA, Isaacs C, Rudra S, Pohlmann P, Ewing C, Wong J, Alvarado M, Jaskowiak N, Prionas N, Golshan M, Piltin MA, Olopade OI, Mukhtar RA. PMID: 40699532; PMCID: PMC12494629.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  4. Risk Factors for Dyspnea in Rib Fracture Patients: A Prospective Study of Patient-Reported Outcomes. J Surg Res. 2025 Aug; 312:15-24. Switalla KM, Sundlof M, Jones E, Bahr M, Doering M, Martin D, McCormick-Deaton J, Melton-Meaux GB, Tignanelli C. PMID: 40499404.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  5. ASO Author Reflections: Reassessing Positive Margins in Breast-Conserving Surgery: The Role of Histology and Oncoplastic Surgery. Ann Surg Oncol. 2025 Sep; 32(9):6691-6692. Switalla KM, Mukhtar RA. PMID: 40481365; PMCID: PMC12317849.
    View in: PubMed Mentions: Fields:
  6. Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype: A Systematic Review and Meta-analysis Evaluating the Impact of Oncoplastic Surgery. Ann Surg Oncol. 2025 Jul; 32(7):4899-4909. Switalla KM, Falade IO, Quirarte A, Baxter M, Kaur M, Sakr RA, Corso G, Mukhtar RA. PMID: 40272667; PMCID: PMC12129873.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  7. Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial. Ann Surg Oncol. 2025 May; 32(5):3278-3291. Boughey JC, Yu H, Switalla K, Velle L, Lopes A, Wallace AM, Lancaster RB, Reyna CR, Tuttle TM, Jaskowiak N, Tchou J, Rao R, Lee MC, Naik AM, Golshan M, Arciero CA, Sauder CAM, Matsen CB, Yau C, Esserman L, Mukhtar RA, I-SPY2 Locoregional Working Group. PMID: 39946078; PMCID: PMC12221658.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  8. Efficacy of topical tranexamic acid in gender-affirming mastectomy. J Plast Reconstr Aesthet Surg. 2025 03; 102:255-261. Falade I, Lopes A, Switalla K, Song S, Ramrakhiani N, Kim E. PMID: 39947111.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  9. Risk factors and resolution of patient-reported pain and mental health symptoms following rib fracture(s). J Trauma Acute Care Surg. 2025 05 01; 98(5):769-775. Sundlof M, Switalla K, Jones EK, Bahr M, Doering M, Martin D, McCormick-Deaton J, Melton-Meaux GB, Tignanelli CJ. PMID: 39760727.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  10. Balancing risks of surgical complications and positive margins for patients with invasive lobular carcinoma of the breast and elevated BMI: An institutional cohort study. Am J Surg. 2025 Mar; 241:116073. Falade I, Switalla K, Quirarte A, Baxter M, Soroudi D, Rothschild H, Abe SE, Goodwin K, Piper M, Alvarado M, Julian BQ, Ewing C, Wong J, Rose J, Esserman L, Foster R, Mukhtar RA. PMID: 39571369; PMCID: PMC12212894.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  11. Variation in surgical treatment by body mass index in patients with invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2024 Dec; 208(3):569-575. Falade IO, Switalla KM, Baxter ME, Quirarte A, Record H, Rothschild HT, Clelland EN, Mukhtar RA. PMID: 39127971; PMCID: PMC11522173.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  12. ASO Author Reflections: Evolving Paradigms in Axillary Management for Breast Cancer: Insights from the ISPY-2 Neoadjuvant Chemotherapy Trial. Ann Surg Oncol. 2024 Oct; 31(11):7260-7261. Switalla KM, Boughey JC, Mukhtar RA. PMID: 39048899.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  13. Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Ann Surg Oncol. 2024 Oct; 31(11):7249-7259. Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA. PMID: 38995451; PMCID: PMC11452431.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  14. Oncologic Safety of Immediate Oncoplastic Surgery Compared with Standard Breast-Conserving Surgery for Patients with Invasive Lobular Carcinoma. Ann Surg Oncol. 2024 Oct; 31(11):7409-7417. Falade I, Switalla K, Quirarte A, Baxter M, Soroudi D, Rothschild H, Abe SE, Goodwin K, Piper M, Wong J, Foster R, Mukhtar RA. PMID: 38713388; PMCID: PMC11452432.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  15. Functional donor-site morbidity following reconstruction with pectoralis major flaps: A systematic review. JPRAS Open. 2024 Mar; 39:278-290. Falade IO, Murphy AI, Switalla KM, Yin RR, Rose JA. PMID: 38370000; PMCID: PMC10874169.
    View in: PubMed Mentions: 4
  16. Effect of beta-blocker therapy on weight loss outcomes after sleeve gastrectomy & Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2023 12; 19(12):1415-1420. Switalla K, Sundlof M, Abdelwahab H, Leslie D, Wise E, Wang Q, Duval S, Benner A, Bartolomucci A, Ikramuddin S. PMID: 37925321.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  17. Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial. Ann Surg Oncol. 2023 Oct; 30(11):6401-6410. Boughey JC, Yu H, Dugan CL, Piltin MA, Postlewait L, Son JD, Edmiston KK, Godellas CV, Lee MC, Carr MJ, Tonneson JE, Crown A, Lancaster RB, Woriax HE, Ewing CA, Chau HS, Patterson AK, Wong JM, Alvarado MD, Yang RL, Chan TW, Sheade JB, Ahrendt GM, Larson KE, Switalla K, Tuttle TM, Tchou JC, Rao R, Tamirisa N, Singh P, Gould RE, Terando A, Sauder C, Hewitt K, Chiba A, Esserman LJ, Mukhtar RA. PMID: 37380911; PMCID: PMC11702681.
    View in: PubMed Mentions: 22 Fields:
    Translation:Humans
  18. Use of endocrine therapy for estrogen receptor-positive breast cancer among American Indians and Alaska natives. Breast Cancer Res Treat. 2023 Apr; 198(2):187-195. Engelking M, Marmor S, Burjak M, Hinojos M, Lloyd W, Switalla KM, Tuttle TM. PMID: 36689093.
    View in: PubMed Mentions: 1 Fields:
    Translation:HumansPHPublic Health

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs